4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0002056093-26-000002
Chief Medical Officer acquired 24,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Markus Richard Chief Medical Officer | 2026-01-23 | Grant or award | +24,000 | 89,647 | D | ||
| Derivatives | |||||||
| Markus Richard Chief Medical Officer | 2026-01-23 | Grant or award · Stock Option (right to buy) | +96,000 | 96,000 | D | ||
Loading xslF345X05/wk-form4_1769476911.xml…